Livento Group, Inc. Files S-1/A Amendment
Ticker: LIVG · Form: S-1/A · Filed: Apr 8, 2024 · CIK: 1593549
| Field | Detail |
|---|---|
| Company | Livento Group, Inc. (LIVG) |
| Form Type | S-1/A |
| Filed Date | Apr 8, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001, $0.009, $0.02, $0.01, $300,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: Livento Group, LIVG, S-1/A, SEC Filing, Amendment
TL;DR
<b>Livento Group, Inc. has filed an S-1/A amendment, providing updated financial information and corporate history.</b>
AI Summary
Livento Group, Inc. (LIVG) filed a Amended IPO Registration (S-1/A) with the SEC on April 8, 2024. Livento Group, Inc. filed an S-1/A amendment on April 8, 2024. The company was formerly known as NuGene International, Inc. and Bling Marketing, Inc. Incorporated in Nevada, with a fiscal year end of December 31. The filing includes financial data for the fiscal years ending December 31, 2023, 2022, and 2021. The filing details preferred stock series A, C, D, E, and F, as well as common stock and additional paid-in capital.
Why It Matters
For investors and stakeholders tracking Livento Group, Inc., this filing contains several important signals. This amendment provides crucial updates for investors regarding the company's financial standing and historical changes. The detailed breakdown of preferred stock series and common stock is essential for understanding the company's capital structure.
Risk Assessment
Risk Level: low — Livento Group, Inc. shows low risk based on this filing. The filing is an S-1/A amendment, indicating ongoing or updated registration efforts, which is standard for companies seeking to go public or make significant changes to their securities, and does not inherently signal immediate financial distress or success.
Analyst Insight
Investors should review the detailed financial statements and disclosures within the S-1/A filing to assess Livento Group's current financial health and strategic direction.
Key Numbers
- 2024-04-08 — Filing Date (Date of S-1/A filing)
- 2023-12-31 — Fiscal Year End (End date of the most recent fiscal year reported)
- 2022-12-31 — Prior Fiscal Year End (End date of the prior fiscal year reported)
- 2021-12-31 — Prior Fiscal Year End (End date of the fiscal year prior to the most recent two)
Key Players & Entities
- Livento Group, Inc. (company) — Filer name
- NuGene International, Inc. (company) — Former company name
- Bling Marketing, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- 17 State Street, New York, NY 10004 (address) — Business and mailing address
- 980 432 8241 (phone) — Business phone number
FAQ
When did Livento Group, Inc. file this S-1/A?
Livento Group, Inc. filed this Amended IPO Registration (S-1/A) with the SEC on April 8, 2024.
What is a S-1/A filing?
A S-1/A is a amendment to an IPO registration statement, typically incorporating SEC feedback. This particular S-1/A was filed by Livento Group, Inc. (LIVG).
Where can I read the original S-1/A filing from Livento Group, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Livento Group, Inc..
What are the key takeaways from Livento Group, Inc.'s S-1/A?
Livento Group, Inc. filed this S-1/A on April 8, 2024. Key takeaways: Livento Group, Inc. filed an S-1/A amendment on April 8, 2024.. The company was formerly known as NuGene International, Inc. and Bling Marketing, Inc.. Incorporated in Nevada, with a fiscal year end of December 31..
Is Livento Group, Inc. a risky investment based on this filing?
Based on this S-1/A, Livento Group, Inc. presents a relatively low-risk profile. The filing is an S-1/A amendment, indicating ongoing or updated registration efforts, which is standard for companies seeking to go public or make significant changes to their securities, and does not inherently signal immediate financial distress or success.
What should investors do after reading Livento Group, Inc.'s S-1/A?
Investors should review the detailed financial statements and disclosures within the S-1/A filing to assess Livento Group's current financial health and strategic direction. The overall sentiment from this filing is neutral.
How does Livento Group, Inc. compare to its industry peers?
Livento Group operates within the software services industry, specifically prepackaged software.
Are there regulatory concerns for Livento Group, Inc.?
The filing is made under the Securities Act of 1933, which governs the initial offering and registration of securities.
Industry Context
Livento Group operates within the software services industry, specifically prepackaged software.
Regulatory Implications
The filing is made under the Securities Act of 1933, which governs the initial offering and registration of securities.
What Investors Should Do
- Analyze the detailed financial statements for fiscal years 2021-2023.
- Review the history of name changes and their potential implications.
- Understand the breakdown of preferred and common stock series.
Key Dates
- 2024-04-08: S-1/A Filing — Amendment to the company's registration statement
- 2015-01-27: Name Change — Formerly known as NuGene International, Inc.
- 2013-12-05: Name Change — Formerly known as Bling Marketing, Inc.
Year-Over-Year Comparison
This is an S-1/A filing, indicating an amendment to a previously filed registration statement, rather than a new initial filing or a periodic report like a 10-K or 10-Q.
Filing Stats: 4,544 words · 18 min read · ~15 pages · Grade level 15.7 · Accepted 2024-04-08 08:10:23
Key Financial Figures
- $0.001 — 3 shares of our Common stock, par value $0.001 per share consisting of (i) 55,555,556
- $0.009 — Financing") using an adjusted price of $0.009 for the per share purchase price, (ii)
- $0.02 — umni Capital LP at an exercise price of $0.02 per share, We may receive proceeds from
- $0.01 — tock as reported on OTCMarkets .com was $0.01. Investing in our Common stock involv
- $300,000 — ypical of a producer, is generally from $300,000 to $700,000. The rest of the costs of t
- $700,000 — producer, is generally from $300,000 to $700,000. The rest of the costs of the movie are
- $500,000 — e Equity Line Investor purchased, up to $500,000 of shares of Common stock in connection
Filing Documents
- forms-1a.htm (S-1/A) — 1396KB
- ex5-1.htm (EX-5.1) — 17KB
- ex23-1.htm (EX-23.1) — 5KB
- forms-1a_001.jpg (GRAPHIC) — 4KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- ex23-001.jpg (GRAPHIC) — 11KB
- 0001493152-24-013417.txt ( ) — 4609KB
- nugn-20231231.xsd (EX-101.SCH) — 32KB
- nugn-20231231_cal.xml (EX-101.CAL) — 42KB
- nugn-20231231_def.xml (EX-101.DEF) — 131KB
- nugn-20231231_lab.xml (EX-101.LAB) — 239KB
- nugn-20231231_pre.xml (EX-101.PRE) — 181KB
- forms-1a_htm.xml (XML) — 558KB
USE OF PROCEEDS
USE OF PROCEEDS 15 CAPITALIZATION 16 DETERMINATION OF OFFERING PRICE 17 MARKET PRICE OF COMMON STOCK AND RELATED STOCKHOLDER MATTERS 17
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 18 SELLING STOCKHOLDERS 19
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 20 SHARES ELIGIBLE FOR FUTURE SALE 21 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES FOR NON-U.S. HOLDERS OF COMMON STOCK 22 PLAN OF DISTRIBUTION 24 LEGAL MATTERS 27 EXPERTS 27 WHERE YOU CAN FIND MORE INFORMATION 27 FINANCIAL F-1 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the "SEC"), using a "shelf" registration process. Under this shelf registration process, the selling stockholders may, from time to time, offer and sell shares of Common stock offered under this prospectus. We will not receive any proceeds from the sale by the selling stockholders of the Common stock offered by them described in this prospectus. We and the selling stockholders have not authorized anyone to provide any information or make any representations other than those contained in this prospectus. We and the selling stockholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the securities offered hereby and only under circumstances and in jurisdictions where it is lawful to do so. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities, in any jurisdiction where the offer or sale is not permitted. The information in this prospectus is current only as of its date. Our business, financial condition, results of operations and prospects may have changed since its date. This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents.